Clinical outcomes of management of CVAD occlusions

Archives of Disease in Childhood

Volumn 96, Issue 9, 2011, Pages 885-887

  Peng, Calvin ^a,b   Monagle, Paul ^a,b,c   Newall, Fiona ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ARTICLE; BRAIN HEMORRHAGE; CATHETER OCCLUSION; CENTRAL VENOUS ACCESS DEVICE OCCLUSION; CENTRAL VENOUS CATHETER; CHILD; DEATH; DRUG EFFICACY; DRUG SAFETY; EMBOLISM; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SURVIVAL TIME; TREATMENT OUTCOME; VASCULAR PATENCY;

ADOLESCENT; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; DRUG EVALUATION; EQUIPMENT FAILURE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; MALE; RETROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 80051817340     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2010.194969     Document Type: Article

References (5)

1. Kerner J.A., Jr Garcia-Careaga M.G., Fisher A.A., et al. Treatment of catheter occlusion in pediatric patients. JPEN J Parenter Enteral Nutr 2006;30:S73-S81 (Pubitemid 43099746)
2. Blaney M., Shen V., Kerner J.A., et al. Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study). J Vasc Interv Radiol 2006;17:1745-1751 (Pubitemid 44800334)
3. Jacobs B R, Haygood M., Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr 2001;139:593-596 (Pubitemid 32977279)
4. Ponec D., Irwin D., Haire W.D., et al. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial-the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Interv Radiol 2001;12:951-955 (Pubitemid 32756865)
5. Stephens L.C., Haire W.D., Kotulak G.D. Are clinical signs accurate indicators of the cause of central venous catheter occlusion? JPEN J Parenter Enteral Nutr 1995;19:75-79